Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mosconi, P.
Right arrow Articles by Maltoni, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosconi, P.
Right arrow Articles by Maltoni, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:S15-S19, 2001
© 2001 European Society for Medical Oncology


Symposium Article

Survival, quality of life and breast cancer

P. Mosconi1, M. Colozza2, M. De Laurentiis3, S. De placido3 and M. Maltoni4

1 Istituto di Ricerche Farmacologiche Mario Negri Milan
2 Policlinico Monteluce Perugia
3 Università Federico II Naples
4 Ospedale Pierantoni Forli, Italy

Correspondence to Dr P. Mosconi Department of Oncology Istituto di Ricerche Farmacologiche Mario Negri Via Eritrea, 62 20157 Milan Italy E-mail: mosconi{at}irfmn.mnegri.it

In recent years, evaluating quality of life (QoL) has become increasingly important as an additional measured outcome in cancer clinical trials, in particular in the field of breast cancer. This paper, after a general introduction to the present debate on the methodological issues involved in QoL evaluation, reviews results and open questions regarding the use of this measure in surgical, adjuvant and metastatic studies.

adjuvant treatment, breast cancer, metastatic disease, quality of life, surgical treatment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
R. Largillier, J.-M. Ferrero, J. Doyen, J. Barriere, M. Namer, V. Mari, A. Courdi, J. M. Hannoun-Levi, F. Ettore, I. Birtwisle-Peyrottes, et al.
Prognostic factors in 1038 women with metastatic breast cancer
Ann. Onc., December 1, 2008; 19(12): 2012 - 2019.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.